ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0610

Nailfold Capillaroscopy for Prediction of Novel Severe Organ Involvement in Systemic Sclerosis

Cristiana Sieiro Santos1, Rúben Rego Salgueiro2, Clara Moriano Morales3, Carolina Álvarez Castro3 and Elvira Díez Álvarez3, 1Complejo Asistencial Universitario de León, León, Spain, 2ULS Guarda, Guarda, Portugal, 3CAULE, León, Spain

Meeting: ACR Convergence 2023

Keywords: calcinosis, Scleroderma

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 12, 2023

Title: (0609–0672) Systemic Sclerosis & Related Disorders – Clinical Poster I: Research

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Nailfold capillaroscopy (NFC) has been suggested as a potential biomarker of disease severity in systemic sclerosis (SSc). Several studies report the association between capillary loss and disease severity however, the association of NFC abnormalities with novel severe organ involvement/progression in SSc has not been evaluated. We aim to evaluate the association of nailfold capillaroscopy (NFC) with novel major organ involvement/progression in SSc.

Methods: Follow-up data from patients with SSc registered between 2000 and 2022 were analysed. Patients underwent NFC at baseline. Novel severe organ involvement/progression was defined as new or progressive involvement of peripheral vasculature, lungs, heart, skin, gastrointestinal, kidney, musculoskeletal at 12 and 24 months of follow-up. The following NFC parameters were evaluated: capillary density, haemorrhages, enlarged and giant capillaries, avascular areas, organization of capillary architecture and scleroderma pattern (early/active/late). Logistic regression modelling was run to assess associations between NFC parameters and the occurrence of novel severe organ involvement and/or progression and risk factors.

Results: 113 patients with SSc were included, 70 patients (61%) developed novel overall severe organ involvement/progression: 39 patients (56%) during the first 12 months and 31 patients (44%) from 12 to24 months of follow-up. 11% of patients developed novel peripheral vascular involvement, 21% developed novel interstitial lung disease (ILD), 11% had progression of known ILD, 6% had novel pulmonary hypertension, 11% had skin progression, 10% had novel heart involvement, 10% had novel gastrointestinal involvement, 6% had scleroderma renal crisis and 13% had novel musculoskeletal involvement. Table 1 summarizes the associations between NFC and novel severe organ involvement/progression during follow-up. Loss of capillary density was associated with overall severe organ involvement (p 0.002), peripheral vascular involvement (p 0.03), new ILD (p 0.04) and skin progression (p 0.01); avascular areas were associated with overall severe organ involvement (p 0.03), new ILD (p 0.03) and progression of ILD (p 0.02) and scleroderma pattern was associated with overall severe organ involvement (p 0.03), peripheral vascular involvement (OR p 0.04), new ILD (p 0.004), progression of ILD (p 0.03) and skin progression (p 0.04).

Conclusion: NFC may be a potential biomarker in SSc for predicting novel severe organ involvement and/or progression. Abnormal capillary density, avascular areas and scleroderma pattern are predictors of overall severe organ involvement, peripheral vascular involvement, novel and progression of ILD and skin progression.

Supporting image 1


Disclosures: C. Sieiro Santos: None; R. Rego Salgueiro: None; C. Moriano Morales: None; C. Álvarez Castro: None; E. Díez Álvarez: None.

To cite this abstract in AMA style:

Sieiro Santos C, Rego Salgueiro R, Moriano Morales C, Álvarez Castro C, Díez Álvarez E. Nailfold Capillaroscopy for Prediction of Novel Severe Organ Involvement in Systemic Sclerosis [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/nailfold-capillaroscopy-for-prediction-of-novel-severe-organ-involvement-in-systemic-sclerosis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/nailfold-capillaroscopy-for-prediction-of-novel-severe-organ-involvement-in-systemic-sclerosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology